Glaxo Sees Return for Two Suspended Drugs (Reuters)
Reuters - GlaxoSmithKline Plc expects to get two
withdrawn drugs back on the U.S. market in the middle of this
year after signing a legal agreement with regulators over a
problem plant in Puerto Rico.
Stumble It!
Tweet This
Bookmark on Delicious
Share on Facebook
Share on MySpace